Picture of BioLife Solutions logo

BLFS — BioLife Solutions News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

BioLife Solutions Inc reports results for the quarter ended in September - Earnings Summary

* BioLife Solutions Inc  BLFS.OQ  reported a quarterly
adjusted
loss of 23 cents​​ per share for the quarter ended in September.
The mean expectation of nine analysts for the quarter was for a
loss of 17 cents per share.
    * Revenue rose 20.6% to $40.75 million from a year ago;
analysts
expected $42.06 million. 
    * BioLife Solutions Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The mean earnings estimate of analysts had risen by
about 13.2%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * BioLife Solutions Inc shares had fallen by 10.5% this
quarter and lost 45.4% so far this year.
    * The company reported a quarterly loss of $9.96 million.
    * Wall Street's median 12-month price target for BioLife
Solutions
Inc is $31.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 10:42 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.17          -0.23          Missed
 Jun. 30 2022      -0.21          -0.06          Beat
 Mar. 31 2022      -0.25          -0.17          Beat
 Dec. 31 2021      -0.17          -0.37          Missed

Recent news on BioLife Solutions

See all news